Brief: Dicot Pharma Q2 Loss After Financial Items At SEK 24.3 Mln
12/08/2025 07:18
Aug 12 (Reuters) - Dicot Pharma AB DICOT.ST: Q2 NET SALES AMOUNTED TO SEK 0.0 (0.0) MILLION Q2 EARNINGS AFTER FINANCIAL ITEMS AMOUNTED TO SEK -24.3 (-13.1) MILLION Source text: ID:nMFNCJ0F6 Further company coverage: DICOT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA